Skip to content
cyclopentolate-(RS)

Structure via PubChem · Public domain (PubChem)

EntityQ867332· pop 19· linked from 425 articles

cyclopentolate-(RS)

Sign in to save

Also known as (+-)-cyclopentolate, beta-(dimethylamino)ethyl (1-hydroxycyclopentyl)phenylacetate, 2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate, alpha-(1-hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester, 1-hydroxy-alpha-phenylcyclopentaneacetic acid 2-(dimethylamino)ethyl ester, 2-phenyl-2-(1-hydroxycyclopentyl)ethanoic acid beta-(dimethylamino)ethyl ester, beta-dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate, 2-(dimethylamino)ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate

Cyclopentolate is a muscarinic antagonist. It is commonly used as an eye drop during pediatric eye examinations to dilate the eye (mydriatic) and prevent the eye from focusing/accommodating (cycloplegic). Cyclopentolate or atropine can also be administered to reverse muscarinic and central nervous system effects of indirect cholinomimetic (anti-AChase) administration.

Chemical data

Formula
C17H25NO3
Molecular weight
291.4 g/mol
IUPAC name
2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate
SMILES
CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O
InChIKey
SKYSRIRYMSLOIN-UHFFFAOYSA-N
XLogP
2.7
Polar surface area
49.8 Ų
H-bond donors
1
H-bond acceptors
4
Formal charge
0

via PubChem

Research

2 papers

via PubMed

Wikidata facts

Mass
291.183444
Show 4 more facts
chemical formula
C₁₇H₂₅NO₃
canonical SMILES
CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O
World Health Organisation international non-proprietary name
cyclopentolate
Commons category
Cyclopentolate
Sources (4)

via Wikidata · CC0

~5 min read

Article

3 sections
Contents
  • History
  • References
  • Further reading

Cyclopentolate is a muscarinic antagonist. It is commonly used as an eye drop during pediatric eye examinations to dilate the eye (mydriatic) and prevent the eye from focusing/accommodating (cycloplegic). Cyclopentolate or atropine can also be administered to reverse muscarinic and central nervous system effects of indirect cholinomimetic (anti-AChase) administration.

It is on the World Health Organization's List of Essential Medicines.

Gallery (3)

Connections

Categories